For appointments and enquiries, you are welcome to contact any of the agents we work with, for information in non-Japanese languages. Please hit the ‘English’ button below to see the contact list of all agents.
- Sep. 25, 2024
- National Cancer Center Hospital on Newsweek’s "World’s Best Specialized Hospitals 2025 (Oncology)"
- Sep. 20, 2024
- HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Receives Its First Regulatory Approval
- Sep. 12, 2024
- Investigator-initiated clinical studies to be launched following confirmation of tumor shrinkage induced by the targeted protein degrader E7820 using J-PDX (Japanese cancer patient-derived tissue transplantation models)
- Aug. 9, 2024
- Start of Fecal Microbiota Transplantation Clinical Study for Esophageal and Gastric Cancer Patients
- Jun. 6, 2024
- Message from New Director